BCC and vismodegib: can we treat and remold at the same time?

G Ital Dermatol Venereol. 2020 Feb;155(1):119-120. doi: 10.23736/S0392-0488.18.06043-1. Epub 2018 May 16.

Authors

Filomena Russo¹, Virginia Mancini², Emanuele Trovato³, Michele Fimiani³, Paolo Taddeucci³

Affiliations

¹ Section of Dermatology, Department of Clinical Medicine and Immunological Science, University of Siena, Siena, Italy - file.russo@libero.it.
² Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, italy.
³ Section of Dermatology, Department of Clinical Medicine and Immunological Science, University of Siena, Siena, Italy.

PMID: 29781264
DOI: 10.23736/S0392-0488.18.06043-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Anilides / administration & dosage*
Antineoplastic Agents / administration & dosage*
Carcinoma, Basal Cell / drug therapy*
Carcinoma, Basal Cell / pathology
Female
Humans
Pyridines / administration & dosage*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Treatment Outcome

Substances

Anilides
Antineoplastic Agents
HhAntag691
Pyridines